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Abstract
Background: Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) is a rare autosomal dominant
disorder characterized by cerebral white matter degeneration and caused by mutations in the colony-stimulating
factor 1 receptor (CSF1R) gene. Involvement of the optic nerves in hereditary diffuse leukoencephalopathy is rare.
Case presentation: We report the case of a 30-year-old Chinese woman with HDLS, who carried a heterozygous
c.2345 G > A (p.782Arg > His) mutation in exon 18 of CSF1R. She developed a gradual decline in motor ability, as well
as cognitive and visual function, over the course of 4 months. Brain T2 fluid-attenuated inversion recovery-weighted
magnetic resonance imaging revealed high signal lesions in the bilateral frontoparietal and periventricular deep white
matter. Optical coherence tomography showed that the right peripapillary retinal nerve fiber layer was atrophic in the
temporal quadrant while the left peripapillary retinal nerve fiber layer was thin in the temporal superior quadrant.
Conclusions: A diagnosis of HDLS should be considered in patients with white matter lesions and optic nerves injury
upon magnetic resonance imaging that mimics progressive multiple sclerosis.
Keywords: Leukoencephalopathy, Colony-stimulating factor 1 receptor, Peripapillary retinal nerve fiber layer, Hereditary
diffuse leukoencephalopathy with axonal spheroids
Background
Hereditary diffuse leukoencephalopathy with axonal
spheroids (HDLS) is a rare autosomal dominant disorder
characterized by cerebral white matter degeneration with
axonal spheroids with variable clinical presentations,
including personality and behavioral changes, dementia,
depression, parkinsonism, and seizures. HDLS was first
identified in a Western Swedish family reported in 1984
[1] and is caused by mutations in the colony-stimulating
factor 1 receptor (CSF1R) gene [2]. HDLS appears as
white matter lesions in a frontal predominant distribu-
tion upon brain magnetic resonance imaging (MRI),
spreading out from the periventricular and deep white
matter into the subcortical areas with enlarged ventricles
and often signal changes in the corpus callosum [3, 4].
However, involvement of the optic nerves has not been
previously reported in HDLS. We describe a HDLS
patient who also had optic nerve lesions.
Case presentation
A 30-year-old, non-smoking woman was referred to our
hospital in August 2015, with a 4-month history of pro-
gressive lower limb weakness, gait disturbance, and vis-
ual disorder. Her mother experienced right lower limb
weakness at 40 years of age, followed by progressive cog-
nitive and motor deterioration and death at 60 years of
age. The case family pedigree is shown in Fig. 1.
Prior to admission to our hospital, the patient exhib-
ited neuropsychiatric symptoms, such as paraphasia and
hallucination. She was diagnosed with multiple sclerosis
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(MS) and received immunotherapy with intravenous
methylprednisolone at another hospital. However, her
motor function progressively declined and she experi-
enced frequent falls. When she was admitted to our hos-
pital, her mini-mental state examination (MMSE) score
was 25/30, with a Montreal cognitive assessment scale
(MoCA) score of 17/30. The activities of daily living
(ADL) score was 50/100 and the Morse fall risk factors
assessment scale score was 45. Bilateral visual acuity was
0.8, muscle tone in her lower limbs increased, and
muscle strength of the lower limbs was grade 4. She
developed a spastic gait and an unsteady broad-based
gait. Romberg’s sign, Babinski’s sign, and Chaddock’s
sign were all positive.
Most laboratory tests were normal/negative, including
the serum erythrocyte sedimentation rate, C-reactive pro-
tein, vitamins (B1\B2\B6\B9\B12), glycosylated hemoglobin,
thyroid function, serum copper, ceruloplasmin, anti-
nuclear antibody, paraneoplastic antibodies, and anti-
bodies specific for the following: myelin oligodendrocyte
glycoprotein, myelin-associated glycoprotein, myelin basic
protein, and aquaporin-4. Serum treponema pallidum
antibody, rapid plasma reagin, tolulized red unheated
serum test, and human immunodeficiency virus antibody
were all negative. Cerebrospinal fluid tests were normal,
including negative oligoclonal IgG bands.
Brain T2 fluid-attenuated inversion recovery (FLAIR)
MRI showed multiple, asymmetrical, hyperintense lesions,
which appeared in periventricular areas and the white
matter regions of the frontal and parietal lobes. Diffusion-
weighted imaging (DWI) showed small dots of diffusion
restriction within the white matter lesions. Magnetic res-
onance spectroscopy (MRS) showed increased levels of
choline (Cho), although N-acetylaspartate (NAA) was de-
creased. Diffusion tensor imaging (DTI) revealed corpus
callosum fiber loss, although fibers of the bilateral frontal,
parietal, occipital, and temporal lobe and brainstem fibers
were spared (Fig. 2).
Fig. 1 Family pedigree. The arrow indicates the proband (present
patient). Her mother developed a motor disorder at 40 years of age
and died at 60 years of age. Her grandparents, father, brothers,
sisters, and daughters were not affected
Fig. 2 Brain MRI, DWI, DTI, and MRS images. T2/Flair showed multifocal periventricular white matter lesions (a b and c), without enhancement (d). DWI
shows high-signal intensities in periventricular white matters and corpus callosum (e f). DTI shows decreased numbers of corpus callosum fibers, while
subcortical arcuate fibers are spared (g). MRS shows increased Cho levels, while NAA levels are decreased in the white matter lesions (h i)
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Optic nerve MRI demonstrated bilateral optic nerves
lesions (Fig. 3). Optical coherence tomography (OCT)
showed that the right peripapillary retinal nerve fiber layer
(pRNFL) was atrophic (pRNFL thickness 43–50 μm) in
the temporal quadrant, and the left pRNFL was thin
(65 μm) in the temporal superior quadrant (Fig. 4). Aver-
age RNFL thickness in healthy controls has been shown to
be 93–108 μm [5]. Visual-evoked potential (VEP) showed
reduced amplitudes of bilateral P100, although latencies of
bilateral P100 were normal (Fig. 5). Bilateral intraocular
pressures (both 15 mmHg) were normal. The visual fields
of both eyes were partially missing in the different quad-
rants (Fig. 6).
Methylprednisolone therapy with two treatment
courses (1000 mg/day for 5 days and 1000 mg/day for
3 days) resulted in no improvement. Genetic studies for
leukodystrophy-related genes showed that a c.2345 G >
A (p.782Arg > His) mutation in exon 18 of CSF1R was
present (Fig. 7), which has been proven to be the patho-
genic gene for HDLS. However, a brain biopsy was
refused by the patient and her family. Seven months
after discharge from our hospital, she showed progres-
sive decline and reached a vegetative state and died on
May 18, 2016.
The present case describes a patient with a genetic-
ally confirmed HDLS and a heterozygous c.2345 G > A
Fig. 3 Optic nerves on MRI, showing that bilateral optic nerves are injured (red arrows)
Fig. 4 OCT shows that the right peripapillary retinal nerve fiber layer (pRNFL) is atrophic in the temporal quadrant, and the left pRNFL is thinning
in the temporal superior quadrants. Green represents pRNFL thickness, which is within normal limits; yellow represents pRNFL thickness, which is
below borderline; red represents pRNFL thickness, which is below normal limits
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(p.782Arg > His) mutation in exon 18 of the CSFR1,
which was previously described by Kinoshita et al. [6].
HDLS has an autosomal dominant pattern of inherit-
ance, and it may be sporadic. In our case, we presume
that the patient’s mother was affected, because of
early-onset motor impairment over the course of her
illness. Unfortunately, however, there were no clinical
data or brain biopsy samples from her mother.
In the present case, the patient experienced visual im-
pairment and optic nerve impairment, which made it
difficult to differentiate the disease from MS. Optic
nerve injury lacking gadolinium enhancement was re-
vealed by brain MRI, and the right temporal pRNFL was
atrophic and left temporal superior pRNFL was thin
upon OCT. To the best of our knowledge, involvement
of the optic nerves has never been reported in HDLS,
Fig. 5 VEP shows reduced bilateral P100 amplitudes, although P100 latencies are normal in both eyes
Fig. 6 Visual fields in the right eye are partially missing in the upper right, lower right, and lower left quadrants, especially in the lower right
quadrant. Visual fields in the left eye are partially missing in the four quadrants, especially in the upper left and lower right quadrants
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and the mechanism of optic nerve impairment in HDLS
remains unknown. HDLS is pathologically characterized
by non-inflammatory myelin loss, reactive astrocytosis,
and axonal spheroids. Axonal spheroids of peripheral
neuropathy have been found in HDLS, suggesting more
widespread nervous system involvement [7]. We hypoth-
esized that non-inflammatory myelin loss and axonal
spheroids might also be involved in the optic nerves in
our HDLS case. Additionally, OCT, which has emerged
as a novel tool to depict neuro-axonal damage in MS by
measuring non-myelinated central nervous system axons
in the retina [5, 8], was also used to analyze RNFL thick-
ness that is the better parameter for monitoring longitu-
dinal axonal damage [9]. RNFL thickness has also been
linked to metabolic signs of neurodegeneration in the vis-
ual cortex [10]. Several reports of MS patients have corre-
lated RNFL atrophy with brain atrophy in patients with
and without optic neuritis [8, 9, 11]. In our case, brain
MRI showed multiple lesions in the white and gray matter,
and DTI revealed lost or spared white and gray matter fi-
bers. These results suggested that RNFL atrophy in OCT
might be associated with brain abnormalities in HDLS.
We hypothesized that the features revealed by OCT and
neuroimaging might be related to axonal and myelin de-
struction in white matter lesions in HDLS.
The clinical features in the present case predominantly
included progressive gait disturbance and cognitive and
motor impairment that mimicked progressive MS,
although the patient also exhibited atypical parkinsonian
features, including bradykinesia and rigidity, which have
been previously reported [12–14]. Although the mecha-
nisms of atypical Parkinsonism remain unclear, it has
been suggested that the disconnected fiber tracts in
white matter lesions are structurally or functionally crit-
ical for performing movements [15, 16]. Subcortical and
periventricular white matter lesions might interfere with
ascending thalamocortical and descending corticospinal
fibers, and a large number of white matter lesions have
been observed in HDLS.
Conclusions
Results from the present case study suggest that optic
nerves can be involved in HDLS. RNFL atrophy ob-
served by OCT might be associated with brain abnor-
malities in HDLS. Molecular analysis of the CSF1R gene
should be performed when HDLS clinically and radio-
logically mimics progressive multiple sclerosis.
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